市場調査レポート

商品コード

1403457

ウェスタンブロッティング市場の2030年までの予測：製品別、用途別、エンドユーザー別、地域別の世界分析

Western Blotting Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Other Products), Application (Clinical Diagnostics, Food & Beverages and Other Applications), End User and By Geography

出版日: 2024年01月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、ウェスタンブロッティングの世界市場は2023年に11億8,000万米ドルを占め、予測期間中のCAGRは8.7％で成長し、2030年には21億1,000万米ドルに達すると予測されています。

タンパク質の分析と検出は、ウェスタンブロッティングとして知られる分子生物学技術の一般的な応用です。ウェスタンブロッティングは、ゲル電気泳動でタンパク質をサイズ別に分離した後、分離したタンパク質をメンブレン上に移すことを含みます。多くの科学的領域で、タンパク質の発現、翻訳後修飾、相互作用の調査にウェスタンブロッティングが利用されています。

米国疾病予防管理センター（CDC）が発表したデータによると、2020年には米国で30,635人がHIVの診断を受けるとされています。

成長促進要因：生物医学研究需要の増加

細胞プロセス、タンパク質発現、相互作用の研究はウェスタンブロッティングによって大いに助けられ、神経生物学やがんなどの分野で重要な新しい理解をもたらしています。生物医学研究の分野が成長し、精密なタンパク質分析の必要性が高まるにつれ、ウェスタンブロッティングは不可欠なものとなっています。さらに、疾患の探求、分子メカニズムの理解、研究結果の検証におけるその汎用性により、ウェスタンブロッティングは基本的なツールとして位置付けられ、バイオメディカル研究コミュニティの進化する要求に応えることができます。

成長抑制要因：初期コストの高さ

ウェスタンブロッティングのコストは、ブロッキング剤、検出基質、抗体を含む高価な試薬や消耗品の使用が必要であることなど、いくつかの理由に起因しています。イメージング装置やゲル電気泳動システムのような特殊なツールも、全体的なコストを引き上げています。さらに、この技術を使うには熟練した人材が必要なため、コストはさらに上昇します。このような検査の実施にかかる費用の高さは、同市場の大きな障害となっています。

機会：政府の取り組みと支援

米国国立衛生研究所（NIH）のような政府機関のイニシアチブは、ウェスタンブロッティング技術を含むプロジェクトに資金を割り当てています。イノベーション、技術進歩、生物医学、医薬品開発、診断における新規用途の調査はすべて、この支援によって奨励されています。さらに、財政的支援は、タンパク質分析および関連研究の開発に有利な環境を作り出し、科学的発見を加速させ、この市場拡大の原動力となっているアクセシビリティを向上させることでサポートしています。

脅威：標準化の欠如

手順、試薬、機器における研究室間の非互換性が結果の再現性を妨げています。調査手法のばらつきはデータの信頼性に影響し、調査結果の比較と検証を困難にしています。標準化に問題があると、ウェスタンブロッティングのイメージが損なわれ、データの正確性に疑念が生じ、研究グループの共同研究が困難になります。

COVID-19の影響

サプライチェーンの混乱、物流の課題、研究室活動の制限により、ウェスタンブロッティング試薬と機器の生産と流通が妨げられました。多くの研究プロジェクトがロックダウンのために遅延または停止し、これらの製品に対する需要に影響を与えました。さらに、COVID-19とは無関係な研究への資金が減少したため、ウェスタンブロッティング研究に利用できるリソースが制限されました。結局、研究の優先順位がCOVID-19にシフトしたため、注目と資源が他の分野から転用されることになった。経済の不確実性がコスト意識を促し、科学界の購買決定に影響を与えています。

予測期間中、機器セグメントが最大となる見込み

分子生物学とタンパク質研究における重要な役割から、機器セグメントが最大のシェアを占めると推定されます。複雑な生物学的サンプルからタンパク質を正確に分離、移動、検出する上で極めて重要な役割を果たしています。メーカーは、迅速な電気泳動、セミドライまたはウェットな移送機能、高度なイメージング技術などの機能を組み込んだ最先端のシステムを研究者に提供するため、絶えず技術革新を行っています。さらに、これらの装置には、タンパク質をサイズに基づいて分離するための電気泳動システム、タンパク質を移送するための移送システム、タンパク質のバンドを可視化・定量化するためのイメージングシステムなどが含まれ、このセグメントの拡大を牽引しています。

バイオ医薬品・バイオテクノロジー企業セグメントは予測期間中に最も高いCAGRが見込まれる

バイオ医薬品・バイオテクノロジー企業セグメントは、医薬品開発、品質管理、調査方法におけるタンパク質分析に使用されるため、予測期間中に最も高いCAGRが見込まれます。この技術は、タンパク質発現の評価、治療標的の検証、製品の一貫性の確保に役立ちます。さらに、タンパク質の特性に関する正確な洞察を提供することで、バイオ医薬品の開発やバイオテクノロジー研究の進展をサポートします。バイオ医薬品の開発・生産における主な利害関係者であり、このセグメントの成長を後押ししています。

最大のシェアを占める地域

北米は、特にバイオテクノロジーとヘルスケア分野における科学研究開発を支援する政府プログラムにより、予測期間中に最大の市場シェアを獲得しました。学術機関、研究機関、業界関係者の協力により、技術革新と応用が促進されます。さらに、これらの製品は現在、食品医薬品局（FDA）などの機関が設定した規制枠組みによって定められた品質基準を満たしており、研究や診断における信頼性を保証しているため、この地域の市場規模を押し上げています。

CAGRが最も高い地域

欧州は、ライフサイエンス研究における検出技術、移送戦略、ゲル電気泳動システムの進歩により、予測期間中に最も高いCAGRを示すと予想されます。研究開発を促進する欧州の政策と、バイオテクノロジーやヘルスケアのイノベーションを支援するイニシアチブが相まって、これらの手順は現在、より正確で効率的なものとなっています。Boster Biological Technology、GE Healthcare、PerkinElmer Inc.、Danaher Corporationなどの主要企業は、厳しい規制政策と品質基準に貢献しており、この地域の成長を牽引しています。

無料カスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

消耗品
- 試薬と緩衝液
- 抗体と複合体
  - 二次抗体
  - 一次抗体
- キット
- 膜と濾紙
- その他の消耗品
機器
- ブロッティングシステム
  - ウェットブロッティングシステム
  - セミドライブロッティングシステム
- 電気泳動装置
- イメージャー
  - 蛍光イメージャ
  - 化学発光イメージャー
その他の製品

第6章世界のウェスタンブロッティング市場：用途別

臨床診断
- ライム病
- 肝炎
- ヒト免疫不全ウイルス（HIV）
- その他の臨床診断
食品・飲料
その他の用途

第7章世界のウェスタンブロッティング市場：エンドユーザー別

病院
バイオ医薬品およびバイオテクノロジー企業
学術研究機関
その他のエンドユーザー

第8章世界のウェスタンブロッティング市場：地域別

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

Abcam Plc
Advansta, Inc.
Azure biosystems, inc.
Bio-Techne Corporation
Boster Biological Technology
Cell signaling technology, inc.
Danaher Corporation
EMD Millipore Corporation
GE Healthcare
Hofmann-La Roche Ltd.
LI-COR, Inc.
Merck Kgaa
PerkinElmer Inc.
Stressmarq biosciences inc.
Thermo Fisher Scientific, Inc.

図表

List of Tables

Table 1 Global Western Blotting Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 4 Global Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 5 Global Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 6 Global Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 7 Global Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 8 Global Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 9 Global Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 10 Global Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 11 Global Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 12 Global Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 13 Global Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 14 Global Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 15 Global Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 16 Global Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 17 Global Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 18 Global Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 19 Global Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 20 Global Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 21 Global Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 22 Global Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 23 Global Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 24 Global Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 25 Global Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 26 Global Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)
Table 27 North America Western Blotting Market Outlook, By Country (2021-2030) ($MN)
Table 28 North America Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 29 North America Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 30 North America Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 31 North America Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 32 North America Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 33 North America Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 34 North America Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 35 North America Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 36 North America Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 37 North America Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 38 North America Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 39 North America Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 40 North America Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 41 North America Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 42 North America Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 43 North America Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 44 North America Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 45 North America Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 46 North America Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 47 North America Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 48 North America Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 49 North America Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 50 North America Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 51 North America Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 52 North America Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)
Table 53 Europe Western Blotting Market Outlook, By Country (2021-2030) ($MN)
Table 54 Europe Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 55 Europe Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 56 Europe Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 57 Europe Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 58 Europe Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 59 Europe Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 60 Europe Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 61 Europe Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 62 Europe Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 63 Europe Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 64 Europe Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 65 Europe Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 66 Europe Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 67 Europe Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 68 Europe Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 69 Europe Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 70 Europe Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 71 Europe Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 72 Europe Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 73 Europe Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 74 Europe Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 75 Europe Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 76 Europe Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 77 Europe Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 78 Europe Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)
Table 79 Asia Pacific Western Blotting Market Outlook, By Country (2021-2030) ($MN)
Table 80 Asia Pacific Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 81 Asia Pacific Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 82 Asia Pacific Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 83 Asia Pacific Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 84 Asia Pacific Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 85 Asia Pacific Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 86 Asia Pacific Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 87 Asia Pacific Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 88 Asia Pacific Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 89 Asia Pacific Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 90 Asia Pacific Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 91 Asia Pacific Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 92 Asia Pacific Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 93 Asia Pacific Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 94 Asia Pacific Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 95 Asia Pacific Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 96 Asia Pacific Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 97 Asia Pacific Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 98 Asia Pacific Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 99 Asia Pacific Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 100 Asia Pacific Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 101 Asia Pacific Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 102 Asia Pacific Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 103 Asia Pacific Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 104 Asia Pacific Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)
Table 105 South America Western Blotting Market Outlook, By Country (2021-2030) ($MN)
Table 106 South America Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 107 South America Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 108 South America Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 109 South America Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 110 South America Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 111 South America Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 112 South America Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 113 South America Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 114 South America Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 115 South America Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 116 South America Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 117 South America Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 118 South America Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 119 South America Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 120 South America Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 121 South America Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 122 South America Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 123 South America Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 124 South America Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 125 South America Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 126 South America Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 127 South America Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 128 South America Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 129 South America Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 130 South America Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)
Table 131 Middle East & Africa Western Blotting Market Outlook, By Country (2021-2030) ($MN)
Table 132 Middle East & Africa Western Blotting Market Outlook, By Product (2021-2030) ($MN)
Table 133 Middle East & Africa Western Blotting Market Outlook, By Consumables (2021-2030) ($MN)
Table 134 Middle East & Africa Western Blotting Market Outlook, By Reagents & Buffers (2021-2030) ($MN)
Table 135 Middle East & Africa Western Blotting Market Outlook, By Antibodies & Conjugates (2021-2030) ($MN)
Table 136 Middle East & Africa Western Blotting Market Outlook, By Kits (2021-2030) ($MN)
Table 137 Middle East & Africa Western Blotting Market Outlook, By Membranes & Filter Papers (2021-2030) ($MN)
Table 138 Middle East & Africa Western Blotting Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 139 Middle East & Africa Western Blotting Market Outlook, By Instruments (2021-2030) ($MN)
Table 140 Middle East & Africa Western Blotting Market Outlook, By Blotting Systems (2021-2030) ($MN)
Table 141 Middle East & Africa Western Blotting Market Outlook, By Electrophoresis Instruments (2021-2030) ($MN)
Table 142 Middle East & Africa Western Blotting Market Outlook, By Imagers (2021-2030) ($MN)
Table 143 Middle East & Africa Western Blotting Market Outlook, By Other Products (2021-2030) ($MN)
Table 144 Middle East & Africa Western Blotting Market Outlook, By Application (2021-2030) ($MN)
Table 145 Middle East & Africa Western Blotting Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 146 Middle East & Africa Western Blotting Market Outlook, By Lyme Disease (2021-2030) ($MN)
Table 147 Middle East & Africa Western Blotting Market Outlook, By Hepatitis (2021-2030) ($MN)
Table 148 Middle East & Africa Western Blotting Market Outlook, By Human Immunodeficiency Virus (HIV) (2021-2030) ($MN)
Table 149 Middle East & Africa Western Blotting Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
Table 150 Middle East & Africa Western Blotting Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 151 Middle East & Africa Western Blotting Market Outlook, By Other Applications (2021-2030) ($MN)
Table 152 Middle East & Africa Western Blotting Market Outlook, By End User (2021-2030) ($MN)
Table 153 Middle East & Africa Western Blotting Market Outlook, By Hospitals (2021-2030) ($MN)
Table 154 Middle East & Africa Western Blotting Market Outlook, By Biopharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 155 Middle East & Africa Western Blotting Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
Table 156 Middle East & Africa Western Blotting Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24682

According to Stratistics MRC, the Global Western Blotting Market is accounted for $1.18 billion in 2023 and is expected to reach $2.11 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Protein analysis and detection are common applications of the molecular biology technique known as western blotting. It involves transferring the separated proteins onto a membrane after they have been separated by size using gel electrophoresis. Numerous scientific domains utilize western blotting to aid in the investigation of protein expression, post-translational modifications, and interactions.

According to data published by the Centers for Disease Control and Prevention (CDC), stated that in 2020, 30,635 people received an HIV diagnosis in the U.S.

Market Dynamics:

Driver:

Increase in biomedical research demand

The study of cellular processes, protein expression, and interactions is greatly aided by western blotting, which provides important new understandings in fields like neurobiology and cancer. It is essential as the field of biomedical research grows and the need for precise protein analysis increases. Furthermore, its versatility in exploring diseases, understanding molecular mechanisms, and validating research findings positions it as a fundamental tool, to meet the evolving demands of the biomedical research community which is driving adoption and innovation of this market's growth.

Restraint:

High initial cost

The cost of Western blotting can be attributed to several reasons, such as the fact that the procedure necessitates the use of costly reagents and consumables, including blocking agents, detection substrates, and antibodies. Specialized tools like imaging equipment and gel electrophoresis systems also raise the overall cost. Furthermore, the cost of using the technique is further increased by the requirement for skilled personnel. The high expense of carrying out these tests is one significant obstacle to the market.

Opportunity:

Government initiatives and support

Initiatives from government bodies, such as the National Institutes of Health (NIH), allocate funds to projects involving Western blotting techniques. Innovation, technical progress, and the investigation of novel uses in biomedicine, medication development, and diagnostics are all encouraged by this support. Furthermore, the financial support creates a favorable environment for developments in protein analysis and related research, speeds up scientific discoveries, and supports by improving accessibility which is driving this market expansion.

Threat:

Lack of standardization

Incompatibilities across laboratories in procedures, reagents, and equipment hinder result reproducibility. Variability in methodologies impacts data reliability, making it challenging for researchers to compare and validate findings. Problems with standardization can damage Western blotting's image, raising doubts regarding the accuracy of the data and making it more difficult for research groups to collaborate.

COVID-19 Impact

Disruptions in supply chains, logistical challenges, and restrictions on laboratory activities have hindered the production and distribution of Western blotting reagents and instruments. Many research projects were delayed or halted due to lockdowns, impacting the demand for these products. Furthermore, the resources available for Western blotting studies have been restricted due to decreased funding for research irrelevant to COVID-19. Eventually, attention and resources have been diverted from other areas due to the shift in research priorities towards COVID-19. Economic uncertainties have prompted cost-consciousness, affecting purchasing decisions in the scientific community.

The instruments segment is expected to be the largest during the forecast period

The instrument segment is estimated to hold the largest share due to its crucial role in molecular biology and protein research. They play a pivotal role in the precise separation, transfer, and detection of proteins from complex biological samples. Manufacturers continually innovate to provide researchers with state-of-the-art systems, incorporating features like rapid electrophoresis, semi-dry or wet transfer capabilities, and advanced imaging technologies. Furthermore, these instruments include electrophoresis systems for separating proteins based on size, transfer systems for transferring proteins, and imaging systems for visualizing and quantifying protein bands, which is driving this segment expansion.

The biopharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The biopharmaceutical & biotechnology companies segment is anticipated to have highest CAGR during the forecast period due to the use of these companies for protein analysis in drug development, quality control, and research processes. The technique aids in assessing protein expression, validating therapeutic targets, and ensuring product consistency. Additionally, by providing precise insights into protein characteristics, it supports the development of biopharmaceuticals and the advancement of biotechnological research. It represents a key stakeholder group in the development and production of biotherapeutics, thereby boosting this segment's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to government programs that support scientific research and development, especially in the biotechnology and healthcare sectors. Collaborations between academic institutions, research organizations, and industry players foster innovation and applications. Furthermore, these now meet quality standards set by regulatory frameworks established by organizations such as the Food and Drug Administration (FDA), guaranteeing dependability in research and diagnostics, thereby propelling this region's size.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period due to advancements in detection technologies, transfer strategies, and gel electrophoresis systems in life sciences research. These procedures are now more accurate and efficient European policies promoting research and development, coupled with initiatives supporting biotechnology and healthcare innovation. Some of the key players including Boster Biological Technology, GE Healthcare, PerkinElmer Inc. and Danaher Corporation contribute to strict regulatory policies and quality standards which are driving this region's growth.

Key players in the market:

Some of the key players in the Western Blotting Market include Abcam Plc, Advansta, Inc., Azure biosystems, inc., Bio-Techne Corporation, Boster Biological Technology, Cell signaling technology, inc., Danaher Corporation, EMD Millipore Corporation, GE Healthcare, Hofmann-La Roche Ltd., LI-COR, Inc., Merck Kgaa, PerkinElmer Inc., Stressmarq biosciences inc. and Thermo Fisher Scientific, Inc.

Key Developments:

In November 2023, GE HealthCare and Masimo announced a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution.

In October 2023, Thermo Fisher Scientific and Olink announced that their respective boards of directors have approved Thermo Fisher's proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash.

In October 2023, GE HealthCare Announces New Innovations and Collaborations in Image Guided Therapy as part of TCT2023 Cardiology Care Pathway Showcase. As clinicians work to treat CVD, cardiology procedures continue to evolve as demand for minimally invasive surgery grows.

Products Covered:

Consumables
Instruments
Other Products

Applications Covered:

Clinical Diagnostics
Food & Beverages
Other Applications

End Users Covered:

Hospitals
Biopharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Western Blotting Market, By Product

5.1 Introduction
5.2 Consumables
- 5.2.1 Reagents & Buffers
- 5.2.2 Antibodies & Conjugates
  - 5.2.2.1 Secondary Antibodies
  - 5.2.2.2 Primary Antibodies
- 5.2.3 Kits
- 5.2.4 Membranes & Filter Papers
- 5.2.5 Other Consumables
5.3 Instruments
- 5.3.1 Blotting Systems
  - 5.3.1.1 Wet Blotting Systems
  - 5.3.1.2 Semi-dry Blotting Systems
- 5.3.2 Electrophoresis Instruments
- 5.3.3 Imagers
  - 5.3.3.1 Fluorescent Imagers
  - 5.3.3.2 Chemiluminescent Imagers
5.4 Other Products

6 Global Western Blotting Market, By Application

6.1 Introduction
6.2 Clinical Diagnostics
- 6.2.1 Lyme Disease
- 6.2.2 Hepatitis
- 6.2.3 Human Immunodeficiency Virus (HIV)
- 6.2.4 Other Clinical Diagnostics
6.3 Food & Beverages
6.4 Other Applications

7 Global Western Blotting Market, By End User

7.1 Introduction
7.2 Hospitals
7.3 Biopharmaceutical & Biotechnology Companies
7.4 Academic & Research Institutes
7.5 Other End Users

8 Global Western Blotting Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Abcam Plc
10.2 Advansta, Inc.
10.3 Azure biosystems, inc.
10.4 Bio-Techne Corporation
10.5 Boster Biological Technology
10.6 Cell signaling technology, inc.
10.7 Danaher Corporation
10.8 EMD Millipore Corporation
10.9 GE Healthcare
10.10 Hofmann-La Roche Ltd.
10.11 LI-COR, Inc.
10.12 Merck Kgaa
10.13 PerkinElmer Inc.
10.14 Stressmarq biosciences inc.
10.15 Thermo Fisher Scientific, Inc.